This paper is only available as a PDF. To read, Please Download here.
A group of 20 pregnant women requesting therapeutic abortion received a single transcervical intrauterine instillation of 5 mg prostaglandin F2α in 5 ml of saline between 38 and 46 days after the onset of their last menses. Of the 20 women, 13 (65%) had a successful termination of pregnancy, while the other 7 patients did not abort. A total of 7 patients, 2 of whom aborted, had severe adverse reactions, including fever, hemorrhage and hypertension. Three of the 5 women who did not abort developed septic incomplete abortions. The low incidence of success and high incidence of complications noted in this study indicate that this method should not be utilized to terminate early pregnancy.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Contraception
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The efficacy and acceptability of the “Prostaglandin Impact” in inducing complete abortion during the second week after the missed menstrual period.Prostaglandins. 1973; 3: 125
- Abortifacient activity of intravenously administered prostaglandins.Contraception. 1971; 3: 121
- Termination of early gestation with vaginal prostaglandin F2αtablets.Prostaglandins. 1972; 2: 453
- Therapeutic abortion of early human gestation with vaginal suppositories of prostaglandin F2α.Am. J. Obstet. Gynec. 1973; 117: 795
- Termination of early pregnancy with prostaglandin E2 vaginal suppositories.Contraception. 1973; 8: 255
- Menstrual extraction: Review of 400 procedures at the Women's Services.Contraception. 1973; 8 (New York, New York): 527
Accepted: February 5, 1974
© 1974 Published by Elsevier Inc.